Skin collagen production-promoting agent
First Claim
1. A method of increasing the collagen content in the skin of a subject comprising orally administering a TGF-β
- degradation product to a subject in recognized need thereof in an amount effective to increase the collagen content in the skin of the subject,wherein the TGF-β
degradation product is acquired by degrading TGF-β
with pancreatin, andwherein the TGF-β
degradation product has an average molecular weight of 500 or more and 8,000 or less.
1 Assignment
0 Petitions
Accused Products
Abstract
A problem of the present invention is to provide a skin collagen production-promoting agent without safety problems. Another problem of the present invention is to provide a skin collagen production-promoting food or drink product and a skin collagen production-promoting cosmetic product containing such a substance. TGF-β and/or a TGF-β degradation product, which is acquired by degrading TGF-β with a protease such as pepsin, pancreatin, etc., are used as a skin collagen production-promoting agent or the active ingredient of a skin collagen production-promoting food or drink product and a skin collagen production-promoting cosmetic product. The aforementioned TGF-β and/or TGF-β degradation product have an effect of increasing the collagen content of the skin.
-
Citations
6 Claims
-
1. A method of increasing the collagen content in the skin of a subject comprising orally administering a TGF-β
- degradation product to a subject in recognized need thereof in an amount effective to increase the collagen content in the skin of the subject,
wherein the TGF-β
degradation product is acquired by degrading TGF-β
with pancreatin, andwherein the TGF-β
degradation product has an average molecular weight of 500 or more and 8,000 or less. - View Dependent Claims (3, 5)
- degradation product to a subject in recognized need thereof in an amount effective to increase the collagen content in the skin of the subject,
-
2. A method of increasing the collagen content in the skin of a subject comprising orally administering 10 μ
- g per day or more of a TGF-β
degradation product to a subject in recognized need thereof to increase the collagen content in the skin of the subject,wherein the TGF-β
degradation product is acquired by degrading TGF-β
with pancreatin, andwherein the TGF-β
degradation product has an average molecular weight of 500 or more and 8,000 or less. - View Dependent Claims (4, 6)
- g per day or more of a TGF-β
Specification